Is Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences's patent grant rate increasing or decreasing?

Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences's recent grant velocity is +40% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences's patents?

Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences's patents average 13.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences

Q: Where does Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences ranks #3,407 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 109 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shanghai ranks #3,407 of 49,997 tracked US assignees by granted-patent volume, with 109 patents across 18 technology areas.

#3,407
of 49,997 US assignees by volume: Top 29%
by Innovation Score (42.9/100): 13.1
avg claims per patent: +40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3407 · Foreign Corporation #3,407 · 109 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MID 109 grants
TOP-DECILE #3,407/49,997
PHOTO-FINISH Neuravi
CPC-FOCUS A61P · 18 areas
INNOV-PAR 42.9/100
CLAIMS-RICH 13.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Neuravi Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cognis IP Management · near

43
Jazz Pharmaceuticals… · near

43
Shanghai Institute… · this assignee

43
Skidata · near

43
Biomet Sports Medicine · near

43
3D Lighting… · lowest

7

What this shows Shanghai's Innovation Score is 42.9/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Shanghai's grants concentrate

Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences is a focused PatentsView assignee: 18 CPC subclasses with 93.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (18 grants) versus a trough of 4 in 2015. By volume, Shanghai sits between Neuravi Limited and SKYPE.

Shanghai's three-year grant acceleration

From 2019–2021 to 2022–2024, Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences moved from 47 to 27 grants (0.57x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,513. See the growth leaderboard.

Neuravi

109
Nucor

109
Progressive Inter…

109
Rittal & KG

109
Siemens Product L…

109
SIG Technology

109
Silgan Dispensing…

109
Skype

109
Shanghai Institut… ◀

109

What this shows Shanghai holds 109 patents at rank #3,406, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shanghai

By rank, the assignees closest to #3,406 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Shanghai's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shanghai, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Cognis IP Management GmbH 43 Skidata GmbH 43 Jazz Pharmaceuticals Ireland Limited 43 Biomet Sports Medicine, LLC 43

Similar claim depth

Nearest assignees by average claims per patent (13.1 here).

Delavan Inc. 13.1 avg Zodiac Aerotechnics 13.1 avg Siemens Gamesa Renewable Energy 13.1 avg Withings 13.1 avg

Shanghai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	3.7%
2016	8	7.3%
2017	6	5.5%
2018	9	8.3%
2019	15	13.8%
2020	18	16.5%
2021	14	12.8%
2022	14	12.8%
2023	6	5.5%
2024	7	6.4%
2025partial year	8	7.3%

Which technologies does Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 102

C07D - Heterocyclic Compounds 86

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 68

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 11

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 10

C07C - Acyclic OR Carbocyclic Compounds 10

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 6

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 5

Y02A - Technologies FOR Adaptation TO Climate Change 5

C07K - Peptides 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C07J - Steroids 3

C08B - POLYSACCHARIDES; Derivatives Thereof 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

Top 15 of 18 technology areas

Where it ranks

Overall rank by patents

#3,407

of 49,997 tracked assignees

Innovation Score

42.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences's patent record in context - here's where to go next.

Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 93.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,407 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences against Neuravi Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.